Gilead gets FDA breakthrough therapy status for Trodelvy
Gilead Sciences (NASDAQ:GILD) said it has received FDA Breakthrough Therapy Designation for its antibody-drug conjugate ...
Multiple Sclerosis News Today1 天
Tolebrutinib for SPMS granted FDA breakthrough therapy designation
Tolebrutinib, expected to soon be submitted for U.S. approval for nonrelapsing SPMS, was granted the FDA's breakthrough ...
Targeted Oncology19 小时
FDA Grants Breakthrough Status to Sacituzumab Govitecan in ES-SCLC
The FDA granted breakthrough therapy designation to sacituzumab govitecan for patients with ES-SCLC progressing on platinum ...
Targeted Oncology1 天
FDA Grants Dostarlimab Breakthrough Therapy Designation in dMMR/MSI-H Rectal Cancer
The FDA granted breakthrough therapy designation to dostarlimab for locally advanced dMMR/MSI-H rectal cancer, highlighting ...
Scientists Crack Cancer’s Hidden Defense With a Breakthrough Protein Discovery
Scientists have discovered a key protein that helps cancer cells avoid detection by the immune system during a type of ...
ADHD breakthrough as experts find some stimulants more effective than therapy in largest ...
New research has found that stimulant drugs and atomoxetine appear to be the best treatments for adults with ADHD - which is ...
Monthly Prescribing Reference1 天
Tobevibart Plus Elebsiran Designated Breakthrough Therapy for Chronic Hepatitis Delta
The Breakthrough Therapy designation is supported by data from the randomized, open-label phase 2 SOLSTICE trial.
Breakthrough gene therapy offers new hope to child with muscular dystrophy
Monroe Carell was a natural fit to offer the new therapy. Its multidisciplinary DMD Clinic, co-directed by Burnette, Soslow ...
JD Supra18 小时
FDA Approves New Biologic Cancer Treatments
Jazz Pharmaceuticals announced that the FDA has approved ZIIHERA® (zanidatamab-hrii) on an accelerated basis for the treatment ...
EurekAlert!6 天
Trial will evaluate breakthrough non-invasive network targeting brain stimulation for upper ...
Kessler scientists' trial set to evaluate non-invasive brain stimulation for upper-extremity disability post-stroke, ...
Yahoo Finance4 天
SNY's Tolebrutinib Gets FDA Breakthrough Therapy Tag for nrSPMS
Sanofi SNY announced that the FDA has granted a Breakthrough Therapy designation to its investigational oral BTK inhibitor, tolebrutinib, for treating adults with non-relapsing secondary ...